Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients.

Zabala A, Bustillo M, Querejeta I, Alonso M, Mentxaka O, González-Pinto A, Ugarte A, Meana JJ, Gutiérrez M, Segarra R.

J Clin Psychopharmacol. 2017 Oct;37(5):569-577. doi: 10.1097/JCP.0000000000000770.

2.

White Matter Tract Integrity in Alzheimer's Disease vs. Late Onset Bipolar Disorder and Its Correlation with Systemic Inflammation and Oxidative Stress Biomarkers.

Besga A, Chyzhyk D, Gonzalez-Ortega I, Echeveste J, Graña-Lecuona M, Graña M, Gonzalez-Pinto A.

Front Aging Neurosci. 2017 Jun 16;9:179. doi: 10.3389/fnagi.2017.00179. eCollection 2017.

3.

Erratum to: Online information seeking by patients with bipolar disorder: results from an international multisite survey.

Conell J, Bauer R, Glenn T, Alda M, Ardau R, Baune BT, Berk M, Bersudsky Y, Bilderbeck A, Bocchetta A, Bossini L, Paredes Castro AM, Cheung EYW, Chillotti C, Choppin S, Del Zompo M, Dias R, Dodd S, Duffy A, Etain B, Fagiolini A, Garnham J, Geddes J, Gildebro J, Gonzalez-Pinto A, Goodwin GM, Grof P, Harima H, Hassel S, Henry C, Hidalgo-Mazzei D, Kapur V, Kunigiri G, Lafer B, Lam C, Larsen ER, Lewitzka U, Licht RW, Lund AH, Misiak B, Piotrowski P, Monteith S, Munoz R, Nakanotani T, Nielsen RE, O'Donovan C, Okamura Y, Osher Y, Reif A, Ritter P, Rybakowski JK, Sagduyu K, Sawchuk B, Schwartz E, Scippa ÂM, Slaney C, Sulaiman AH, Suominen K, Suwalska A, Tam P, Tatebayashi Y, Tondo L, Vieta E, Vinberg M, Viswanath B, Volkert J, Zetin M, Zorrilla I, Whybrow PC, Bauer M.

Int J Bipolar Disord. 2017 Dec;5(1):18. doi: 10.1186/s40345-017-0082-8. Epub 2017 Mar 31. No abstract available.

4.

Psychoeducational preventive treatment for women at risk of postpartum depression: study protocol for a randomized controlled trial, PROGEA.

Ugarte AU, López-Peña P, Vangeneberg CS, Royo JG, Ugarte MA, Compains MT, Medrano MP, Toyos NM, Lamo EA, Dueñas MB, González-Pinto A.

BMC Psychiatry. 2017 Jan 13;17(1):13. doi: 10.1186/s12888-016-1162-5.

5.

Online psycho-education to the treatment of bipolar disorder: protocol of a randomized controlled trial.

González-Ortega I, Ugarte A, Ruiz de Azúa S, Núñez N, Zubia M, Ponce S, Casla P, Llano JX, Faria Á, González-Pinto A.

BMC Psychiatry. 2016 Dec 22;16(1):452. doi: 10.1186/s12888-016-1159-0.

6.

Peripheral Inflammatory Parameters in Late-Life Depression: A Systematic Review.

Martínez-Cengotitabengoa M, Carrascón L, O'Brien JT, Díaz-Gutiérrez MJ, Bermúdez-Ampudia C, Sanada K, Arrasate M, González-Pinto A.

Int J Mol Sci. 2016 Dec 2;17(12). pii: E2022. Review.

7.

The Efficacy of Non-Pharmacological Interventions on Brain-Derived Neurotrophic Factor in Schizophrenia: A Systematic Review and Meta-Analysis.

Sanada K, Zorrilla I, Iwata Y, Bermúdez-Ampudia C, Graff-Guerrero A, Martínez-Cengotitabengoa M, González-Pinto A.

Int J Mol Sci. 2016 Oct 24;17(10). pii: E1766. Review.

8.

Psychometric properties and validation of a four-item version of the Strauss-Carpenter scale in bipolar disorder.

Alberich S, Barbeito S, González-Ortega I, Ugarte A, Vega P, de Azúa SR, López P, Zorrilla I, González-Pinto A.

Int J Bipolar Disord. 2016 Dec;4(1):22. Epub 2016 Oct 18.

9.

Online information seeking by patients with bipolar disorder: results from an international multisite survey.

Conell J, Bauer R, Glenn T, Alda M, Ardau R, Baune BT, Berk M, Bersudsky Y, Bilderbeck A, Bocchetta A, Bossini L, Paredes Castro AM, Cheung EY, Chillotti C, Choppin S, Del Zompo M, Dias R, Dodd S, Duffy A, Etain B, Fagiolini A, Garnham J, Geddes J, Gildebro J, Gonzalez-Pinto A, Goodwin GM, Grof P, Harima H, Hassel S, Henry C, Hidalgo-Mazzei D, Kapur V, Kunigiri G, Lafer B, Lam C, Larsen ER, Lewitzka U, Licht R, Lund AH, Misiak B, Piotrowski P, Monteith S, Munoz R, Nakanotani T, Nielsen RE, O'Donovan C, Okamura Y, Osher Y, Reif A, Ritter P, Rybakowski JK, Sagduyu K, Sawchuk B, Schwartz E, Scippa ÂM, Slaney C, Sulaiman AH, Suominen K, Suwalska A, Tam P, Tatebayashi Y, Tondo L, Vieta E, Vinberg M, Viswanath B, Volkert J, Zetin M, Zorrilla I, Whybrow PC, Bauer M.

Int J Bipolar Disord. 2016 Dec;4(1):17. doi: 10.1186/s40345-016-0058-0. Epub 2016 Aug 24. Erratum in: Int J Bipolar Disord. 2017 Dec;5(1):18.

10.

Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History.

González-Pinto A, González-Ortega I, Alberich S, Ruiz de Azúa S, Bernardo M, Bioque M, Cabrera B, Corripio I, Arango C, Lobo A, Sánchez-Torres AM, Cuesta MJ; PEPs Group.

PLoS One. 2016 Aug 11;11(8):e0160949. doi: 10.1371/journal.pone.0160949. eCollection 2016.

11.

Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial.

González-Ortega I, Echeburúa E, García-Alocén A, Vega P, González-Pinto A.

Trials. 2016 Jul 29;17:372. doi: 10.1186/s13063-016-1507-x.

12.

Prognostic Value of Affective Symptoms in First-Admission Psychotic Patients.

Arrasate M, González-Ortega I, García-Alocén A, Alberich S, Zorrilla I, González-Pinto A.

Int J Mol Sci. 2016 Jun 30;17(7). pii: E1039. doi: 10.3390/ijms17071039.

13.

Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review.

García S, Martínez-Cengotitabengoa M, López-Zurbano S, Zorrilla I, López P, Vieta E, González-Pinto A.

J Clin Psychopharmacol. 2016 Aug;36(4):355-71. doi: 10.1097/JCP.0000000000000523. Review.

14.

Discrimination between Alzheimer's Disease and Late Onset Bipolar Disorder Using Multivariate Analysis.

Besga A, Gonzalez I, Echeburua E, Savio A, Ayerdi B, Chyzhyk D, Madrigal JL, Leza JC, Graña M, Gonzalez-Pinto AM.

Front Aging Neurosci. 2015 Dec 14;7:231. doi: 10.3389/fnagi.2015.00231. eCollection 2015.

15.

Risk Factors for Emergency Department Short Time Readmission in Stratified Population.

Besga A, Ayerdi B, Alcalde G, Manzano A, Lopetegui P, Graña M, González-Pinto A.

Biomed Res Int. 2015;2015:685067. doi: 10.1155/2015/685067. Epub 2015 Nov 17.

16.

Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies.

Fernandes BS, Molendijk ML, Köhler CA, Soares JC, Leite CM, Machado-Vieira R, Ribeiro TL, Silva JC, Sales PM, Quevedo J, Oertel-Knöchel V, Vieta E, González-Pinto A, Berk M, Carvalho AF.

BMC Med. 2015 Nov 30;13:289. doi: 10.1186/s12916-015-0529-7.

17.

A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.

Bioque M, Llerena A, Cabrera B, Mezquida G, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Aguilar EJ, Bulbena A, Castro-Fornieles J, Vieta E, Lafuente A, Mas S, Parellada M, Saiz-Ruiz J, Cuesta MJ, Bernardo M; PEPs GROUP.

Int J Neuropsychopharmacol. 2016 Mar 31;19(4). pii: pyv121. doi: 10.1093/ijnp/pyv121. Print 2016 Apr.

18.

Age at First Episode Modulates Diagnosis-Related Structural Brain Abnormalities in Psychosis.

Pina-Camacho L, Del Rey-Mejías Á, Janssen J, Bioque M, González-Pinto A, Arango C, Lobo A, Sarró S, Desco M, Sanjuan J, Lacalle-Aurioles M, Cuesta MJ, Saiz-Ruiz J, Bernardo M, Parellada M; PEPs Group.

Schizophr Bull. 2016 Mar;42(2):344-57. doi: 10.1093/schbul/sbv128. Epub 2015 Sep 14.

19.

BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year.

Martinez-Cengotitabengoa M, MacDowell KS, Alberich S, Diaz FJ, Garcia-Bueno B, Rodriguez-Jimenez R, Bioque M, Berrocoso E, Parellada M, Lobo A, Saiz PA, Matute C, Bernardo M, Gonzalez-Pinto A, Leza JC; FLAMM-PEPs.

Schizophr Bull. 2016 Jan;42(1):142-51. doi: 10.1093/schbul/sbv078. Epub 2015 Jun 30.

20.

Bipolar disorder comorbid with alcohol use disorder: focus on neurocognitive correlates.

Balanzá-Martínez V, Crespo-Facorro B, González-Pinto A, Vieta E.

Front Physiol. 2015 Apr 7;6:108. doi: 10.3389/fphys.2015.00108. eCollection 2015. Review.

Supplemental Content

Loading ...
Support Center